abemaciclib in patients with p16ink4a negative, relapsed mesothelioma
Published 3 years ago • 152 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
1:34
personalized therapy in thoracic malignancies
-
3:40
treatment with eribulin in metastatic breast cancer
-
8:22
molecular profiling in early breast cancer
-
3:40
pembrolizumab showed clinical benefit in malignant pleural mesothelioma
-
1:20
ctcs, emt & immunosuppresive cells in metastatic breast cancer
-
2:12
liquid biopsies first to make treatment decisions in patients with metastatic nsclc
-
7:08
atezolizumab, cobimetinib, and eribulin in patients with metastatic inflammatory breast cancer
-
19:53
bce 64 salicylate poisoning
-
48:13
mesothelioma, myths, misperceptions, and surgical options, elizabeth a. david, m.d.
-
0:40
dr. raffit hassan on avelumab in unresectable mesothelioma
-
7:12
case 16 | pathologists online
-
0:36
breast biopsy
-
0:38
metastatic primary peritoneal serous carcinoma
-
5:23
keynote-598: pembro ipi in metastatic nsclc
-
9:28
19 s3p1 stone
-
0:44
sibley memorial hospital interventional pulmonology
-
2:48
immunomodulatory effects of parp inhibition in brca1-deficient triple-negative breast cancer
-
7:11
chemotherapeutics in metastatic breast cancer